Annovis Bio, Inc. Quarterly Return On Equity in % from Q4 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Annovis Bio, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2019 to Q3 2024.
  • Annovis Bio, Inc. Return On Equity for the quarter ending September 30, 2024 was 2.83K %.
  • Annovis Bio, Inc. annual Return On Equity for 2023 was -565 %, a 705% decline from 2022.
  • Annovis Bio, Inc. annual Return On Equity for 2022 was -70.2 %, a 74.5% decline from 2021.
  • Annovis Bio, Inc. annual Return On Equity for 2021 was -40.2 %, a 32.1% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 2.83K +3.05K Jul 1, 2024 Sep 30, 2024
Q2 2024 2.78K +2.91K Apr 1, 2024 Jun 30, 2024
Q1 2024 -1.17K -1.07K -1090% Jan 1, 2024 Mar 31, 2024
Q4 2023 -565 -495 -705% Oct 1, 2023 Dec 31, 2023
Q3 2023 -220 -161 -275% Jul 1, 2023 Sep 30, 2023
Q2 2023 -129 -82.6 -179% Apr 1, 2023 Jun 30, 2023
Q1 2023 -98 -61.8 -170% Jan 1, 2023 Mar 31, 2023
Q4 2022 -70.2 -30 -74.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -58.6 -20.2 -52.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -46.3 +2.2 +4.54% Apr 1, 2022 Jun 30, 2022
Q1 2022 -36.2 +71.5 +66.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -40.2 +19.1 +32.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -38.4 +38 +49.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -48.5 +348 +87.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 -108 -142 -412% Jan 1, 2021 Mar 31, 2021
Q4 2020 -59.3 -71.4 -591% Oct 1, 2020 Dec 31, 2020
Q3 2020 -76.4 Jul 1, 2020 Sep 30, 2020
Q2 2020 -396 Apr 1, 2020 Jun 30, 2020
Q1 2020 34.5 Jan 1, 2020 Mar 31, 2020
Q4 2019 12.1 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.